Paper · 23737439
Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M and 7 others. J Bone Miner Res, 2013. Cited by 123 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. Papers, record 23737439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23737439
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Morphogenetic Proteins | Major topic |
| Bone and Bones | Major topic |
| Carbonic Anhydrases | Major topic |
| Glycoproteins | Major topic |
| Minerals | Major topic |
| Osteocytes | Major topic |
| Adaptor Proteins, Signal Transducing | |
| Animals | |
| Calcium | |
| Cell Line | |
| Cell Size | |
| Enzyme Induction | |
| Gene Expression Regulation | |
| Gene Knockdown Techniques | |
| Genetic Markers | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Intercellular Signaling Peptides and Proteins | |
| Mice | |
| RNA, Small Interfering | |
| Recombinant Proteins |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 24,166,807 | Osteocytes: regulating the mineral reserves? | https://conductscience.org/library/papers/24166807 |
Source PubMed
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,971,253 | Sclerostin downregulation in aseptic loosening. | Bone Joint Res | 2026 | https://conductscience.org/library/papers/42971253 | PubMed |
| 42,502,704 | Sost deficiency leads to greater bone vascular porosity, but similar osteocyte lacunar properties with increasing age. | Bone Rep | 2026 | https://conductscience.org/library/papers/42502704 | PubMed |
| 42,403,364 | Periodontitis as a Model for Inflammatory Uncoupling of Bone Remodeling. | J Periodontal Res | 2026 | https://conductscience.org/library/papers/42403364 | PubMed |
| 42,027,593 | Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study. | Bone Rep | 2026 | https://conductscience.org/library/papers/42027593 | PubMed |
| 41,294,494 | Effect of Orthodontic Tooth Movement on Sclerostin Expression in Alveolar Bone Matrix: A Systematic Review of Studies on Animal Models. | Dent J (Basel) | 2025 | https://conductscience.org/library/papers/41294494 | PubMed |
| 41,035,133 | 3D Osteocyte Networks under Pulsatile Unidirectional Fluid Flow Stimuli (PUFFS). | ACS Biomater Sci Eng | 2025 | https://conductscience.org/library/papers/41035133 | PubMed |
| 40,355,125 | Impact of elevated sclerostin levels on bone resorption : unravelling structural changes and mineral metabolism disruption. | Bone Joint Res | 2025 | https://conductscience.org/library/papers/40355125 | PubMed |
| 40,352,664 | Localized sclerostin accumulation in osteocyte lacunar-canalicular system is associated with cortical bone microstructural alterations and bone fragility in db/db male mice. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40352664 | PubMed |
| 39,820,728 | Decreasing miR-433-3p Activity in the Osteoblast Lineage Blunts Glucocorticoid-mediated Bone Loss. | Endocrinology | 2025 | https://conductscience.org/library/papers/39820728 | PubMed |
| 39,741,885 | Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39741885 | PubMed |
1 to 10 of 79
See all 79 cited byGenes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACP5 | 54 | PubTator's text mining | https://conductscience.org/library/genes/54 | NCBI Gene |
| CA2 | 760 | PubTator's text mining | https://conductscience.org/library/genes/760 | NCBI Gene |
| CTSK | 1,513 | PubTator's text mining | https://conductscience.org/library/genes/1513 | NCBI Gene |
| SOST | 50,964 | PubTator's text mining | https://conductscience.org/library/genes/50964 | NCBI Gene |
| TNFSF11 | 8,600 | PubTator's text mining | https://conductscience.org/library/genes/8600 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23737439
GET https://conductscience.org/api/papers/v1/23737439/cited_by?page=2